Guilford, CT, United States of America

Demetrios Braddock

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 100(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: **Demetrios Braddock: Innovator in Medical Treatments and Pathological Disorders**

Introduction

Demetrios Braddock is a distinguished inventor based in Guilford, CT, who holds an impressive portfolio of 21 patents. His work primarily focuses on compositions and methods aimed at treating various medical disorders, particularly those associated with calcification and nephrolithiasis.

Latest Patents

Among his latest innovations are groundbreaking patents that include "Compositions for treating ectopic calcification disorders, and methods using same," which presents compositions and methods for addressing diseases linked to pathological calcification or ossification. Another notable patent is titled "Compositions and methods for reducing progression of nephrolithiasis," which details methods for treating and preventing kidney stones using specific ENPP1 and ENPP3 polypeptides, or their mutant variants.

Career Highlights

Demetrios Braddock has built a career rich in impactful contributions, with notable positions at Yale University. His expertise and innovative mindset have led to significant advancements in medical treatments, paving the way for improved patient outcomes.

Collaborations

Demetrios has partnered with fellow professionals, including Ronald Albright and Clemens Bergwitz. These collaborations enhance the breadth of knowledge and innovation within his field of expertise.

Conclusion

Through his inventive work and collaborations, Demetrios Braddock continues to make noteworthy contributions to medical science. His patents and ongoing research serve as a testament to his dedication and expertise, driving forward the frontier of treatments for complex medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…